Advanced search×

American Academy of Allergy, Asthma and Immunology (AAAAI)-2010 annual meeting. 26 February-2 March 2010, New Orleans, LA, USA.

IDrugs 13(5):304-7 (2010) PMID 20432184

The 2010 American Academy of Allergy, Asthma and Immunology (AAAAI) meeting, held in New Orleans, included topics covering new therapeutic developments in the fields of allergy, asthma and immunological diseases. This conference report highlights selected presentations on potential treatments for food and other allergies, as well as therapies for asthma and other immunological diseases. Investigational drugs discussed include Oralair Mites (Stallergenes SA/Paladin Labs Inc), PF-03654746 (Pfizer Inc) and AMG-853 (Amgen Inc).

Version: za2963e q8za1 q8zb8 q8zc5 q8zd8 q8zec q8zfc q8zg8

Similar articles you may find interesting…

  1. Adverse events after flu vaccination in patients with immune disorders.

    Hong Kong Med J 16(2):159 (2010) PMID 20354258

  2. The role of acid and bile reflux in oesophagitis and Barrett's metaplasia.

    Biochem Soc Trans 38(2):348-52 (2010) PMID 20298181 PMCID PMC3072824

    The precise mechanisms whereby gastro-oesophageal reflux disease causes reflux oesophagitis and Barrett's oesophagus are not clear, even though these diseases have been known to be linked for many years. Recent studies indicate a role for the reflux-induced inflammatory response of oesophageal squam...
  3. [Psychiatric and psychological complications in obstructive sleep apnea syndrome].

    Pneumonol Alergol Pol 79(1):26-31 (2011) PMID 21190150

    We can distinguish: the male sex, race, overweight and obesity, thyroid hypofunction, age and alcohol abuse. Obstructive sleep apnea results in the absence (apnea) or reduction (hypopnea) of airflow lasting at least 10 s despite normal respiratory exertion. The apnea and hypopnea result in decreased...